Zobrazeno 1 - 10
of 67
pro vyhledávání: '"R. Van der Wieken"'
Publikováno v:
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation. 13(12)
Hypothermia can cause several ECG changes which can be mistaken for other cardiac diseases, most importantly acute transmural ischaemia. These ECG changes correlate strongly with the degree of hypothermia and the prognosis of the patient. This brief
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3d259a828e24d65b50ebe5a7d34d287a
https://pubmed.ncbi.nlm.nih.gov/25696444
https://pubmed.ncbi.nlm.nih.gov/25696444
Autor:
Christoph A. Nienaber, D Andresen, Keaven M. Anderson, Joel C Scherer, P Coussement, Ian Menown, Martin J. Frey, C M Gibson, J.A. de Lemos, T.C Rehders, Carolyn H. McCabe, R. Van der Wieken, Eugene Braunwald, Elliott M. Antman, Robert P. Giugliano, F. Van de Werf
Publikováno v:
European Heart Journal. 21:1944-1953
Aims Abciximab has previously been shown to enhance thrombolysis and improve myocardial perfusion when combined with reduced doses of alteplase. The purpose of the reteplase phase of TIMI 14 was to evaluate the effects of abciximab when used in combi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7eb45a25f4d7d8afb185418c8d3fb426
https://doi.org/10.1053/euhj.2000.2243
https://doi.org/10.1053/euhj.2000.2243
Autor:
P. Zijnen, E Altmann, Eelko Ronner, C.A Cuffie-Jackson, Karl-Ludwig Neuhaus, L. R. van der Wieken, H A M van Kesteren, Peter Molhoek, M. L. Simoons
Publikováno v:
European Heart Journal. 21:1530-1536
Aims Thrombolytic therapy restores coronary patency in patients with acute myocardial infarction, although normal perfusion (TIMI 3 flow) is not achieved in all patients. In an attempt to improve TIMI 3 flow, a combination of full-dose streptokinase,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f575ca6ac5471f0216551e56af5021b5
https://doi.org/10.1053/euhj.1999.2035
https://doi.org/10.1053/euhj.1999.2035
Autor:
Frans Van de Werf, Eugene Braunwald, Sabina A. Murphy, Martin J. Frey, James A. de Lemos, Carolyn H. McCabe, C. Michael Gibson, Robert P. Giugliano, Stephanie Coulter, Keaven M. Anderson, R. Van der Wieken, Elliott M. Antman, Joel C Scherer
Publikováno v:
Circulation. 101:239-243
Background —In the presence of ST-elevation myocardial infarction, patients with successful epicardial reperfusion (TIMI 3 flow) but persistent ST elevation on a 12-lead ECG are at high risk for subsequent death and left ventricular dysfunction. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc783cb52ff34e4c60f92c9634b411d1
https://doi.org/10.1161/01.cir.101.3.239
https://doi.org/10.1161/01.cir.101.3.239
Autor:
P Coussement, Alec Vahanian, Elliott M. Antman, Keaven M. Anderson, Carolyn H. McCabe, A.A.Jennifer Adgey, John Ducas, Joel C Scherer, Frans Van de Werf, Eugene Braunwald, Neal S. Kleiman, Ian B. A. Menown, Robert P. Giugliano, R. Van der Wieken, Hans J. Rupprecht, C. Michael Gibson
Publikováno v:
Circulation. 99:2720-2732
Background —The TIMI 14 trial tested the hypothesis that abciximab, the Fab fragment of a monoclonal antibody directed to the platelet glycoprotein (GP) IIb/IIIa receptor, is a potent and safe addition to reduced-dose thrombolytic regimens for ST-s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50b9ac22daafdc5b837eb7400990386e
https://doi.org/10.1161/01.cir.99.21.2720
https://doi.org/10.1161/01.cir.99.21.2720
Publikováno v:
European Heart Journal. 19:1608-1616
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bb12e19d88d6d692c5dbe2b3d918116
https://doi.org/10.1053/euhj.1998.1222
https://doi.org/10.1053/euhj.1998.1222
Autor:
Jan G.P. Tijssen, GertJan Laarman, Ferdinand Kiemeneij, L. R. van der Wieken, Ton Slagboom, J. S. M. Suwarganda
Publikováno v:
Heart. 72:12-15
BACKGROUND--Is it safe to discharge patients from hospital on the same day as percutaneous transluminal coronary angioplasty (PTCA)? The hypothesis tested was that careful pre and post angioplasty selection of patients can identify a group that is at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee3e10dfbe29614c58fcfc5f0972e8de
https://doi.org/10.1136/hrt.72.1.12
https://doi.org/10.1136/hrt.72.1.12
Autor:
Wolfgang Rutsch, D de Bono, Gr. Heyndrickx, J. C. A. Hoorntje, M. L. Simoons, M. J. De Boer, T F Schaible, L R van der Wieken, M. van den Brand, A. J. M. Van Miltenburg
Publikováno v:
Circulation. 89:596-603
BACKGROUND Patients with unstable angina despite intensive medical therapy, ie, refractory angina, are at high risk for developing thrombotic complications: myocardial infarction or coronary occlusion during percutaneous transluminal coronary angiopl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::448628603877911abb70135fe411378b
https://doi.org/10.1161/01.cir.89.2.596
https://doi.org/10.1161/01.cir.89.2.596
Publikováno v:
BMJ. 323:464-466
The consumption of recreational drugs has reached epidemic proportions. Forty five million European Union citizens have used cannabis at some time, with proportionately higher use among younger people.1 The consumption of harder drugs such as cocaine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63d7bf7f0ea41f671179b90382430da5
https://doi.org/10.1136/bmj.323.7311.464
https://doi.org/10.1136/bmj.323.7311.464
Autor:
H. W. Vliegen, E. E. van der Wall, M. G. Niemeyer, N. J. Holwerda, P. J. L. M. Bernink, P. de Weerd, A. H. Bosma, L. R. van der Wieken, A. J. M. Timmermans, G. P. Molhoek, P. G. H. Mulder
Publikováno v:
Journal of Cardiovascular Pharmacology. 18:S55-S60
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c7b2a3b42d569c8f129abf63e3953fd
https://doi.org/10.1097/00005344-199106189-00012
https://doi.org/10.1097/00005344-199106189-00012